States and Medicare Push for Broader Coverage of Obesity Treatments
The article explores how individuals in competitive, appearance-driven industries are using GLP-1 weight-loss drugs like Ozempic to maintain a professional edge, highlighting personal stories of conflict, expense, and societal pressures to conform to beauty standards.